The effect of nebulized bronchodilator therapy on intraocular pressures in patients with glaucoma

L Kalra, MF Bone - Chest, 1988 - Elsevier
A controlled double-blind crossover study of ocular complications associated with nebulized
ipratropium bromide and salbutamol therapy for respiratory distress was undertaken in 46 …

Ocular hazards of nebulized bronchodilators

KM Mulpeter, JB Walsh, M O'Connor… - Postgraduate …, 1992 - academic.oup.com
Ocular hazards of nebulized bronchodilators Page 1 Postgrad Med J (1992) 68, 132- 133 )
The Fellowship of Postgraduate Medicine, 1992 Ocular hazards of nebulized …

Acute angle-closure glaucoma resulting from treatment with nebulised bronchodilators

Y Fernandez-Barrientos, M Jimenez-Santos… - Archivos de la …, 2006 - europepmc.org
Discussion Nebulised ipratropium bromide and salbutamol increases the intraocular
pressure and may cause an AACG in susceptible patients (those with a shallow anterior …

Effect of beclomethasone nasal spray on intraocular pressure in ocular hypertension or controlled glaucoma

D Yuen, YM Buys, YP Jin, T Alasbali… - Journal of …, 2013 - journals.lww.com
Purpose To evaluate the effect of 6 weeks administration of beclomethasone nasal spray on
intraocular pressure (IOP) in patients with ocular hypertension or controlled primary open …

Effect of nebulized ipratropium bromide on intraocular pressures in children

WTA Watson, EP Shuckett, AB Becker, FER Simons - Chest, 1994 - Elsevier
Study objective To evaluate the effects of nebulized ipratropium bromide on intraocular
pressures and pupillary responses in children with asthma. Design A double-blind …

Acute closure-angle glaucoma after treatment with ipratropium bromide and salbutamol aerosols

M De Saint Jean, T Bourcier, V Borderie… - Journal Francais D' …, 2000 - europepmc.org
We report a case of acute angle-closure glaucoma in a patient treated with bronchodilator
nebulization. An 82-year-old man with chronic obstructive bronchopathy was treated for …

Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade.

WH Frishman, M Kowalski, S Nagnur… - Heart disease …, 2001 - europepmc.org
Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …

Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients

A Waldock, J Snape, CM Graham - British journal of ophthalmology, 2000 - bjo.bmj.com
AIMS To evaluate the short term cardiovascular, respiratory, and intraocular pressure (IOP)
effects of four glaucoma medications in newly diagnosed glaucoma patients. METHODS 141 …

Minimum concentration of levobunolol required to control intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension

D Long, T Zimmerman, G Spaeth, G Novack… - American journal of …, 1985 - Elsevier
In a double-masked, randomized, comparison titration study to determine the effective dose
of topically applied levobunolol, three concentrations of levobunolol (0.25%, 0.5%, and 1%) …

Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension

JA Han, WH Frishman, SW Sun, PM Palmiero… - Cardiology in …, 2008 - journals.lww.com
Glaucoma and ocular hypertension are highly prevalent conditions in individuals over the
age of 40 and are commonly seen together in patients with cardiovascular disease. Many of …